About
Sophie is an associate in our London office.
Additional Information
- Advising HBX Group International on its 2025 IPO on the Barcelona, Bilbao, Madrid and Valencia Stock Exchanges
- Advising Cenergy Holdings SA on its €200 million capital increase by way of a public offer in Belgium and Greece and private placements in various jurisdictions
- Advising Aston Martin Lagonda on its £111 million non-pre-emptive equity placing in 2024
- Advising CVC in connection with the sell-downs of Synsam shares in 2024 and 2025
- Advising Sanofi on the separation and spin-off of Opella, its consumer healthcare business
- Advising AstraZeneca on its collaboration and investment agreement with Cellectis

Sophie Desch
Associate
London Office
100 Bishopsgate
EC2P 2SR London